What will be the impact of Technological Advancements in Interventional Oncology on Global Industry

The global interventional oncology market is projected to reach USD 2.9 billion by 2024 from USD 2.0 billion in 2019, at a CAGR of 6.8%

ID: 1547738
recent pressrelease next pressrelease

(businesspress24) - According to the new market research report "Interventional Oncology Market by Product (Radiofrequency, microwave, cryoablation, embolization, guidewires), Procedures (Thermal Ablation, Non-Thermal Ablation, TACE, TARE, TAE), Cancer (Liver, Lung, Kidney, Bone Metastasis) - Global Forecast to 2024", published by MarketsandMarkets

Rising preference for minimally invasive procedures, increasing public-private funding and government support for cancer research, technological advancements in the field of interventional oncology, and increasing government investments and funding for interventional oncology and related cancer research are some of the major factors driving the growth of this market.

Don''t miss out on business opportunities in Interventional Oncology Market

Speak to Subject Expert:
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=203687164

The TARE/SIRT segment accounted for the largest share of the Interventional Oncology Market, by procedure, in 2018

Based on procedure, the Interventional Oncology Market is segmented into thermal tumor ablation, non-thermal tumor ablation, transcatheter arterial chemoembolization (TACE), transcatheter arterial radioembolization (TARE) or selective internal radiation therapy (SIRT), and transcatheter arterial embolization (TAE) or bland embolization. In 2018, the TARE/SIRT procedures segment accounted for the largest market share majorly due to the rising prevalence of cancer, increasing demand for minimally invasive procedures, growing adoption of embolization procedures, and the clinical efficacy of Yttrium-90 radioembolic agents (which are used in these procedures).

Browse and in-depth TOC on "Interventional Oncology Market"

140
33
180

Liver cancer segment to register the highest CAGR in the Interventional Oncology Market, by application, during the forecast period

Based on cancer type, the Interventional Oncology Market is segmented into liver cancer, kidney cancer, lung cancer, bone cancer, and other cancers (includes pediatric cancer, prostate cancer, and breast cancer). Growth in this segment can be attributed to factors such as rising cases of liver cancer across the globe and growing initiatives/research activities for developing advanced liver cancer therapies using interventional oncology.



Download an Illustrative overview of the report:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=203687164

North America accounted for the largest share of the Interventional Oncology Market in 2018

The Interventional Oncology Market is segmented into four regional segments, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the Interventional Oncology Market owing to factors such as the rising incidence of cancer, easy accessibility to interventional oncology, and the high adoption of technological advancements (owing to the significant per capita annual healthcare expenditure by the US government).

The major players operating in the Interventional Oncology Market are Medtronic (Ireland), Boston Scientific (US), BTG plc (UK), Merit Medical Systems (US), and Terumo (Japan). The other prominent players operating in the overall Interventional Oncology Market include AngioDynamics (US), Ethicon (part of J&J) (US), Teleflex (US), Cook Medical (US), HealthTronics (US), MedWaves Medical (US), Sanarus (US), IMBiotechnologies (Canada), Trod Medical (US), IceCure Medical (Israel), Mermaid Medicals (Denmark), and Interface Biomaterials BV (Netherlands).

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=203687164



More information:
http://https://www.marketsandmarkets.com/Market-Reports/interventional-oncology-market-203687164.html



Keywords (optional):

interventional-oncology-market, interventional-oncology-market-growth, interventional-oncology-market-size, interventional-oncology-market-analysis, interventional-oncology-market-outlook, interventional-oncology-market-latest-trends, oncology,



Company information / Profile:

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies'' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets''s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

PressRelease by

Requests:



PressContact / Agency:

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales(at)marketsandmarkets.com



published by: dheerajshaha67
print pressrelease  send to a friend  

Date: 03/18/2019 - 07:59
Language: English
News-ID 1547738
Character count: 4200
Kontakt-Informationen:
Firma: MnM
Ansprechpartner: Shelly Singh Feedback to businesspress24.com about Pressrelease-id:
Stadt: Northbrook
Telefon: 8886006441

Meldungsart: Financial
Versandart: send
Freigabedatum: 18.03.2019
Comments:



Number of hits: 439

Linking-Tips:



Direct Link to this PressRelease:






We would appreciate a link in your News-, Press- or Partner-Site.

Comments on this PressRelease






All members: 9 247
Register today: 0
Register yesterday: 4
Members online: 2
Guests online: 63


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.